异基因造血干细胞移植术后黏膜相关恒定 T (MAIT)细胞与发生常见病毒感染的差异及 危险因素分析
Analysis of the Differences and Risk Factors between Mucosa-Associated Invariant T (MAIT) Cells and Common Viral Infections after Allogeneic Hematopoietic Stem Cell Transplantation
摘要: 黏膜相关恒定T (MAIT)细胞作为一种先天样T细胞,在维持黏膜免疫稳态中起关键作用,但其在allo-HCT后的动态变化及其与移植后病毒感染的关联尚待深入探讨。本研究纳入42例首次接受allo-HCT的患者。在预处理前及移植后第30 (±3)天,通过流式细胞术检测外周血MAIT细胞(CD3 + TCRVα7.2 + CD161+)频率,通过受试者工作特征(ROC)曲线确定MAIT细胞计数的临界值,将患者分为高、低组,统计分析MAIT细胞水平与移植后常见病毒(CMV、EBV及BKV)感染及临床因素之间的相关性。本研究表明,allo-HCT后早期(第30天)的外周血MAIT细胞数量是预测BKV血症风险的潜在重要生物标志物。GVHD预防方案中的环磷酰胺(PTCy)可能会抑制MAIT细胞的早期重建,从而可能增加移植后感染等相关并发症风险。监测MAIT细胞动态变化有助于早期识别高危患者并进行干预。
Abstract: Mucosa-Associated Invariant T (MAIT) cells, as a type of innate T cells, play a key role in maintaining mucosal immune homeostasis. However, their dynamic changes after allo-HCT and their association with viral infections after transplantation remain to be further explored. This study included 42 patients who received allo-HCT for the first time. Before pretreatment and on the 30th (±3) day after transplantation, the frequency of MAIT cells (CD3 + TCRVα7.2 + CD161+) in peripheral blood was detected by flow cytometry. The critical value of MAIT cell count was determined by the Receiver Operating Characteristic (ROC) curve, and the patients were divided into high and low groups. Statistically analyze the correlation between MAIT cell levels and common viral (CMV, EBV and BKV) infections and clinical factors after transplantation. This study indicates that the number of MAIT cells in the peripheral blood in the early stage (day 30) after allo-HCT is a potentially important biomarker for predicting the risk of BKKV syndrome. Cyclophosphamide (PTCy) in the GVHD prevention protocol may inhibit the early reconstitution of MAIT cells, thereby potentially increasing the risk of related complications such as infection after transplantation. Monitoring the dynamic changes of MAIT cells is helpful for the early identification of high-risk patients and intervention.
文章引用:刘振凯, 李庆生. 异基因造血干细胞移植术后黏膜相关恒定 T (MAIT)细胞与发生常见病毒感染的差异及 危险因素分析 [J]. 临床医学进展, 2026, 16(2): 2009-2017. https://doi.org/10.12677/acm.2026.162597

参考文献

[1] Blazar, B.R., Hill, G.R. and Murphy, W.J. (2020) Dissecting the Biology of Allogeneic HSCT to Enhance the GvT Effect Whilst Minimizing GvHD. Nature Reviews Clinical Oncology, 17, 475-492. [Google Scholar] [CrossRef] [PubMed]
[2] Shapiro, R.M. and Antin, J.H. (2020) Therapeutic Options for Steroid-Refractory Acute and Chronic GVHD: An Evolving Landscape. Expert Review of Hematology, 13, 519-532. [Google Scholar] [CrossRef] [PubMed]
[3] Demosthenous, C., Sakellari, I., Douka, V., Papayanni, P.G., Anagnostopoulos, A. and Gavriilaki, E. (2021) The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-Versus-Host Disease (GVHD). Journal of Clinical Medicine, 10, Article 2050. [Google Scholar] [CrossRef] [PubMed]
[4] Alexander, T. and Greco, R. (2022) Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases: Overview and Future Considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation, 57, 1055-1062. [Google Scholar] [CrossRef] [PubMed]
[5] Law, N., Logan, C. and Taplitz, R. (2024) EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes. Viruses, 16, Article 1294. [Google Scholar] [CrossRef] [PubMed]
[6] Reantragoon, R., Corbett, A.J., Sakala, I.G., Gherardin, N.A., Furness, J.B., Chen, Z., et al. (2013) Antigen-loaded MR1 Tetramers Define T Cell Receptor Heterogeneity in Mucosal-Associated Invariant T Cells. Journal of Experimental Medicine, 210, 2305-2320. [Google Scholar] [CrossRef] [PubMed]
[7] Hinks, T.S.C., van Wilgenburg, B., Wang, H., Loh, L., Koutsakos, M., Kedzierska, K., et al. (2020) Study of MAIT Cell Activation in Viral Infections in Vivo. In: Methods in Molecular Biology, Springer, 261-281. [Google Scholar] [CrossRef] [PubMed]
[8] Gapin, L. (2009) Where Do MAIT Cells Fit in the Family of Unconventional T Cells? PLOS Biology, 7, e1000070. [Google Scholar] [CrossRef] [PubMed]
[9] Velikkakam, T., Gollob, K.J. and Dutra, W.O. (2022) Double-Negative T Cells: Setting the Stage for Disease Control or Progression. Immunology, 165, 371-385. [Google Scholar] [CrossRef] [PubMed]
[10] Gao, M.G. and Zhao, X.S. (2022) Mining the Multifunction of Mucosal-Associated Invariant T Cells in Hematological Malignancies and Transplantation Immunity: A Promising Hexagon Soldier in Immunomodulatory. Frontiers in Immunology, 13, Article 931764. [Google Scholar] [CrossRef] [PubMed]
[11] Bhattacharyya, A., Hanafi, L., Sheih, A., Golob, J.L., Srinivasan, S., Boeckh, M.J., et al. (2018) Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation, 24, 242-251. [Google Scholar] [CrossRef] [PubMed]
[12] Ye, P., Pei, R., Hu, Y., Chen, D., Li, S., Cao, J., et al. (2022) Posaconazole Oral Suspension for Secondary Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation Recipients: A Retrospective Study. BMC Infectious Diseases, 22, Article No. 465. [Google Scholar] [CrossRef] [PubMed]
[13] Gooptu, M. and Antin, J.H. (2021) GVHD Prophylaxis 2020. Frontiers in Immunology, 12, Article 605726. [Google Scholar] [CrossRef] [PubMed]
[14] Zhang, C., Chen, S., Bian, Y., Qian, X., Liu, Y., Zhao, L., et al. (2024) Prediction of Intravenous Immunoglobulin Retreatment in Children with Kawasaki Disease Using Models Combining Lymphocyte Subset and Cytokine Profile in an East Asian Cohort. Clinical & Translational Immunology, 13, e1498. [Google Scholar] [CrossRef] [PubMed]
[15] Chung, H. (2025) CMV Infections after HSCT: Prophylaxis and Treatment. Blood Research, 60, Article No. 33. [Google Scholar] [CrossRef] [PubMed]
[16] Oksuz, L., Yestepe, M.E., Önel, M., et al. (2022) The Association of CMV Infection with Bacterial and Fungal Infections in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Single-Center Study. The New Microbiologica, 45, 40-50.
[17] Giménez, E., Torres, I., Albert, E., Piñana, J., Hernández-Boluda, J., Solano, C., et al. (2019) Cytomegalovirus (CMV) Infection and Risk of Mortality in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT): A Systematic Review, Meta-Analysis, and Meta-Regression Analysis. American Journal of Transplantation, 19, 2479-2494. [Google Scholar] [CrossRef] [PubMed]
[18] Wang, J., Su, M., Wei, N., Yan, H., Zhang, J., Gong, Y., et al. (2024) Chronic Active Epstein-Barr Virus Disease Originates from Infected Hematopoietic Stem Cells. Blood, 143, 32-41. [Google Scholar] [CrossRef] [PubMed]
[19] Howson, L.J., Salio, M. and Cerundolo, V. (2015) MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases. Frontiers in Immunology, 6, Article 303. [Google Scholar] [CrossRef] [PubMed]
[20] Lukens, J.R., Barr, M.J., Chaplin, D.D., et al. (2012) Inflammasome-Derived IL-1β Regulates the Production of GM-CSF by CD4(+) T Cells and γδ T Cells. The Journal of Immunology, 188, 3107-3115. [Google Scholar] [CrossRef] [PubMed]
[21] Seth, A., Vogel, P., Sommers, M., Ong, T. and Pillai, A.B. (2017) Bidirectional Immune Tolerance in Nonmyeloablative MHC-Mismatched BMT for Murine β-Thalassemia. Blood, 129, 3017-3030. [Google Scholar] [CrossRef] [PubMed]
[22] Mhandire, K., Saggu, K. and Buxbaum, N.P. (2021) Immunometabolic Therapeutic Targets of Graft-Versus-Host Disease (GvHD). Metabolites, 11, Article 736. [Google Scholar] [CrossRef] [PubMed]